ABEO - ABEONA THERAPEUTICS INC.
5.755
-0.645 -11.208%
Share volume: 2,303,997
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$6.40
-0.65
-0.10%
View ratios
Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
Report Date | 05-15-2024 | 08-08-2023 | 11-13-2023 | 11-14-2024 | 05-15-2024 | 08-12-2024 | 11-14-2024 | 03-20-2025 | |
Total revenue | 0.000 | 3.500 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Gross profit | 0.000 | 3.500 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
inf% | -100.00% | nan% | nan% | nan% | nan% | ||||
Operating expenses | 12.038 M | 13.544 M | 11.304 M | 13.209 M | 14.330 M | 17.864 M | 15.345 M | 16.672 M | |
Selling general and admin | 3.997 M | 5.021 M | 4.156 M | 5.830 M | 7.123 M | 8.646 M | 6.404 M | 7.678 M | |
Research and development | 8.041 M | 8.523 M | 7.148 M | 7.379 M | 7.207 M | 9.218 M | 8.941 M | 8.994 M | |
Total expenses | 12.038 M | 14.054 M | 11.334 M | 13.209 M | 14.330 M | 17.864 M | 15.345 M | 16.672 M | |
16.75% | -19.35% | 16.54% | 8.49% | 24.66% | -14.10% | 8.65% | |||
Operating income | -12.038 M | -10.554 M | -11.334 M | -13.209 M | -14.330 M | -17.864 M | -15.345 M | -16.672 M | |
Ebit | -9.773 M | -19.183 M | -12.435 M | -17.439 M | -31.631 M | 7.063 M | -30.501 M | -9.897 M | |
Pretax income | -9.510 M | -18.869 M | -11.947 M | -16.805 M | -31.740 M | 7.182 M | -30.414 M | -9.956 M | |
98.41% | -36.68% | 40.66% | 88.87% | -122.63% | -523.48% | -67.27% | |||
Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income | -9.107 M | -16.654 M | -11.836 M | -16.591 M | -31.578 M | 7.406 M | -30.269 M | -9.293 M | |
-82.87% | 28.93% | -40.17% | -90.33% | 123.45% | -508.71% | 69.30% |